Use of principal component analysis and molecular docking to identify novel 
selective plasmepsin II inhibitors.

Valiente, P. A.; Wolf, M. G.; Guerra, Y.; Sierra, Y.; Wacker, S.; Pascual, I.; Pons, T.; Groenhof, G.

doi:10.1111/j.1742-4658.2010.08705.x

アイテム詳細

登録内容を編集ファイル形式で保存

一時保存へ追加

タグ情報を表示リリース履歴を表示詳細要約

公開

会議抄録

Use of principal component analysis and molecular docking to identify novel selective plasmepsin II inhibitors.

MPS-Authors

/persons/resource/persons41407

Wolf, M. G.
Department of Theoretical and Computational Biophysics, MPI for biophysical chemistry, Max Planck Society;

/persons/resource/persons15977

Wacker, S.
Research Group of Computational Biomolecular Dynamics, MPI for biophysical chemistry, Max Planck Society;

/persons/resource/persons15149

Groenhof, G.
Department of Theoretical and Computational Biophysics, MPI for biophysical chemistry, Max Planck Society;

External Resource

http://onlinelibrary.wiley.com/doi/10.1111/j.1742-4658.2010.08705.x/pdf
(出版社版)

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

フルテキスト (公開)

公開されているフルテキストはありません

付随資料 (公開)

There is no public supplementary material available

引用

Valiente, P. A., Wolf, M. G., Guerra, Y., Sierra, Y., Wacker, S., Pascual, I., Pons, T., & Groenhof, G. (2012). Use of principal component analysis and molecular docking to identify novel selective plasmepsin II inhibitors. FEBS Journal, 279(Supplement 1), 447-447. doi:10.1111/j.1742-4658.2010.08705.x.

引用: https://hdl.handle.net/11858/00-001M-0000-000F-EFDC-8

要旨

要旨はありません